Cargando…
New approaches to symptomatic treatments for Alzheimer’s disease
BACKGROUND: Successful development of agents that improve cognition and behavior in Alzheimer’s disease (AD) is critical to improving the lives of patients manifesting the symptoms of this progressive disorder. DISCUSSION: There have been no recent approvals of cognitive enhancing agents for AD. The...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805095/ https://www.ncbi.nlm.nih.gov/pubmed/33441154 http://dx.doi.org/10.1186/s13024-021-00424-9 |